ICAD Insider Trading

Insider Ownership Percentage: 10.29%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $0.00

iCAD Insider Trading History Chart

This chart shows the insider buying and selling history at iCAD by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$100k-$50k$0$50k$100kTotal Insider BuyingTotal Insider Selling

iCAD Share Price & Price History

Current Price: $3.73
Price Change: Price Decrease of -0.01 (-0.27%)
As of 05/23/2025 05:00 PM ET

This chart shows the closing price history over time for ICAD up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
JulAugSepOctNovDecJanFebMarAprMay$3.73Closing price on 05/25/25:

iCAD Insider Trading History

See Full Table

SEC Filings (Institutional Ownership Changes) for iCAD (NASDAQ:ICAD)

24.61% of iCAD stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at ICAD by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table
2022202320242025$5.78Mbought$1.24MsoldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$4M-$2M$0$2M$4MTotal InflowsTotal Outflows
iCAD logo
iCAD, Inc. engages in the provision of cancer detection and therapy solutions in the United States. It operates through two segments, Detection and Therapy. The company provides ProFound AI for digital breast tomosynthesis and 2D mammography; PowerLook, a density assessment solution; and ProFound Risk, a breast cancer risk analysis. The company was formerly known as Howtek, Inc. and changed its name to iCAD, Inc. in June 2002. iCAD, Inc. was incorporated in 1984 and is headquartered in Nashua, New Hampshire.
Read More on iCAD

Today's Range

Now: $3.73
Low: $3.63
High: $3.77

50 Day Range

MA: $2.84
Low: $1.66
High: $3.99

52 Week Range

Now: $3.73
Low: $1.18
High: $4.02

Volume

274,795 shs

Average Volume

407,299 shs

Market Capitalization

$102.37 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.35

Who are the major institutional investors of iCAD?

iCAD's top institutional investors include:
  1. Parkman Healthcare Partners LLC — 2.85%
  2. Informed Momentum Co LLC — 1.05%
  3. Universal Beteiligungs und Servicegesellschaft mbH — 0.89%
  4. Jane Street Group LLC — 0.32%
  5. Summit Trail Advisors LLC — 0.27%
  6. NewEdge Advisors LLC — 0.18%
Learn More about top institutional investors of iCAD stock.

Which major investors are selling iCAD stock?

In the last quarter, ICAD stock was sold by these institutional investors:
  1. Greenwood Capital Associates LLC
  2. Summit Trail Advisors LLC
  3. Salem Investment Counselors Inc.
  4. NewEdge Advisors LLC

Which major investors are buying iCAD stock?

During the previous quarter, ICAD stock was acquired by institutional investors including:
  1. Parkman Healthcare Partners LLC
  2. Informed Momentum Co LLC
  3. Universal Beteiligungs und Servicegesellschaft mbH
  4. Jane Street Group LLC
  5. Ethos Financial Group LLC
  6. Cubist Systematic Strategies LLC
  7. Thompson Davis & CO. Inc.
  8. Goldman Sachs Group Inc.